In a filing, Intellia Therapeutics Inc revealed its EVP, General Counsel BASTA JAMES unloaded Company’s shares for reported $75778.0 on Mar 04 ’24. In the deal valued at $32.99 per share,2,297 shares were sold. As a result of this transaction, BASTA JAMES now holds 81,571 shares worth roughly $1.93 million.
Then, Clark Eliana sold 605 shares, generating $19,959 in total proceeds. Upon selling the shares at $32.99, the EVP, Chief Technical Officer now owns 71,470 shares.
Before that, Sepp-Lorenzino Laura sold 2,275 shares. Intellia Therapeutics Inc shares valued at $65,682 were divested by the EVP, Chief Scientific Officer at a price of $28.87 per share. As a result of the transaction, Sepp-Lorenzino Laura now holds 43,927 shares, worth roughly $1.04 million.
Goldman downgraded its Intellia Therapeutics Inc [NTLA] rating to a Neutral from a a Buy in a research note published on February 23, 2024; the price target was decreased to $32 from $136. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”a Peer perform”‘ rating. Canaccord Genuity began covering NTLA with “Buy” recommendation on April 13, 2023. Bernstein started covering the stock on March 21, 2023. It rated NTLA as “an Outperform”.
Price Performance Review of NTLA
On Monday, Intellia Therapeutics Inc [NASDAQ:NTLA] saw its stock jump 0.51% to $23.72. Over the last five days, the stock has gained 7.92%. Intellia Therapeutics Inc shares have fallen nearly -22.20% since the year began. Nevertheless, the stocks have fallen -45.66% over the past one year. While a 52-week high of $47.48 was reached on 02/29/24, a 52-week low of $19.37 was recorded on 04/26/24. SMA at 50 days reached $25.98, while 200 days put it at $29.97. A total of 1.49 million shares were traded, compared to the trading of 1.22 million shares in the previous session.
Levels Of Support And Resistance For NTLA Stock
The 24-hour chart illustrates a support level at 23.38, which if violated will result in even more drops to 23.04. On the upside, there is a resistance level at 24.19. A further resistance level may holdings at 24.66. The Relative Strength Index (RSI) on the 14-day chart is 51.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.66, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 22.60%. Stochastics %K at 78.07% indicates the stock is a holding.
